Atripla

Background

ATRIPLA®: The first and only complete HIV (Human Immunodeficiency Virus) regimen in one pill daily. ATRIPLA® is a prescription medicine used alone as a complete regimen or with other medicines to treat HIV infection in adults.

EMTRIVA®: TRUVADA® combines EMTRIVA® and VIREAD® in one tablet taken once a day in combination with other antiretroviral agents. In the United States, TRUVADA® is indicated in combination with other antiretroviral agents (such as non-nucleoside reverse transcriptase inhibitors or protease inhibitors) for the treatment of HIV-1 infection in adults. Safety and efficacy studies using TRUVADA® tablets or using EMTRIVA® and VIREAD® in combination are ongoing.

Therapeutic Area

Anti-Infective (HIV/AIDS)

Acquisition Date

Jul 2005

Marketer

Seller